Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kent

Showing results (941-950 of 1,017) with videos related to

Pageof 102
Sort By:
Ejhaem|February 23, 2023
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapyThi H O Nguyen, Chhay Lim, Masa Lasica, et al.
Science Advances|July 21, 2023
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infectionWen Shi Lee, Hyon-Xhi Tan, Arnold Reynaldi, et al.
Frontiers in Immunology|June 3, 2022
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron VariantNagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Nature Nanotechnology|September 8, 2018
Minimum information reporting in bio-nano experimental literatureMatthew Faria, Mattias Björnmalm, Kristofer J Thurecht, et al.
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Science Translational Medicine|February 16, 2018
Circulating T<sub>FH</sub> cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunityMarios Koutsakos, Adam K Wheatley, Liyen Loh, et al.
The Journal of Clinical Investigation|July 11, 2024
Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccineWen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
JCI Insight|January 9, 2025
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccinesWen Shi Lee, Kevin J Selva, Jennifer Audsley, et al.
Pageof 102

Showing results (941-950 of 1,017) with videos related to

Sort By:
Pageof 102
Ejhaem|February 23, 2023
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapyThi H O Nguyen, Chhay Lim, Masa Lasica, et al.
Science Advances|July 21, 2023
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infectionWen Shi Lee, Hyon-Xhi Tan, Arnold Reynaldi, et al.
Frontiers in Immunology|June 3, 2022
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron VariantNagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Nature Nanotechnology|September 8, 2018
Minimum information reporting in bio-nano experimental literatureMatthew Faria, Mattias Björnmalm, Kristofer J Thurecht, et al.
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Science Translational Medicine|February 16, 2018
Circulating T<sub>FH</sub> cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunityMarios Koutsakos, Adam K Wheatley, Liyen Loh, et al.
The Journal of Clinical Investigation|July 11, 2024
Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccineWen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
JCI Insight|January 9, 2025
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccinesWen Shi Lee, Kevin J Selva, Jennifer Audsley, et al.
Pageof 102